|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma显示文摘 | Dudley ME Wunderlich J Nishimura MI | 2001 | J Immunother2001，24，4： | 1 |
| 2 | Minimal determinant expressed by a recombinant vaccinia virus elicits therapeutic antitumor cytolytic T lymphocyte responses显示文摘 | Irvine KR Nishimura MI | 1995 | Cancer Res1995，55，8： | 1 |
| 3 | Regulatory balance between the immune response of tumor antigen-specific T-cell receptor genetransdueed CD8 + T cells and the suppressive effects of tolerogenie dendritic cells显示文摘 | Fujii S Nishimura MI Lotze MT | 2005 | Cancer Sci2005，96，12： | 1 |
| 4 | Regulatory balance between the immune response of tumor antigen-specific T-cell receptor genetransduced CD8 + T cells and the suppressive effects of tolerogenic dendritic cells显示文摘 | Fujii S Nishimura MI Lotze MT | 2005 | Cancer Sci2005，96，12： | 1 |
| 5 | Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy 显示文摘 | Diaz-Montero CM Salem ML Nishimura MI | 2009 | Cancer Immunol Immunother2009，58，1： | 1 |
| 6 | Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorabicin-eyclophosphamide chemotherapy 显示文摘 | Diaz-Montero CM Salem ML Nishimura MI Garrett-Mayer E Cole DJ Montero AJ | 2009 | Cancer Immunol Immunother2009，58，1： | 1 |
| 7 | Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin- cyclophosphamide chemotherapy显示文摘 | Diaz-Montero CM Salem ML Nishimura MI | 2009 | Cancer Immunol Immunother2009，58，1： | 1 |
| 8 | Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage,metastatic tumor burden,and doxorubicin-cyclophosphamide chemotherapy显示文摘 | Diaz-Montero CM Salem ML Nishimura MI | 2009 | Cancer Immunol Immunother2009，58，1： | 1 |
| 9 | Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin- cyclophosphamide chemotherapy显示文摘 | Diaz-Montero CM Salem ML Nishimura MI | 2009 | Cancer Immunol Immunother2009，58，1： | 1 |
| 10 | Increased cir-culating myeloid -derived suppressor cells correlate with clinicalcancer stage, metastatic tumor burden, and doxorubicin-cyclophos-phamide chemotherapy 显示文摘 | Di az -Montero CM Salem ML Nishimura MI | 2009 | Cancer Immunol Immunother2009，58，1： | 1 |
| 11 | Regulatory balance between the immune response of tumor antigen - specific T -cell receptor gene - transduced CD8 T cells and the suppressive effects of tolerogenic dendritic cells 显示文摘 | Fujii S Nishimura MI Lotze MT | 2005 | Cancer Sci2005，96，12： | 1 |
| 12 | Increased circulating myeloid - derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin - cyclo- phosphamide chemotherapy 显示文摘 | Diaz - Montero CM Salem ML Nishimura MI | 2009 | Cancer Immunol lmmunother2009，58，1： | 1 |
| 13 | Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence,and its blockade restores hepatocyte-directed in vitro cytotoxicity显示文摘 | McMahan RH Golden-Mason L Nishimura MI | | 0，，： | 1 |
| 14 | Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclo- phosphamide chemotherapy 显示文摘 | Diaz-Montero CM Salem ML Nishimura MI | 2009 | Cancer Immunol Immunother2009，58，： | 1 |
| 15 | In- creased circulating myeloid-derived suppressor ceils corre- late with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy 显示文摘 | Diaz-Montero CM Salem ML Nishimura MI | 2009 | Cancer Immunol Immunother2009，58，1： | 1 |
| 16 | Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy 显示文摘 | Diaz-Montero CM Salem ML Nishimura MI | 2009 | Cancer Immunol Immunother2009，58，： | 1 |
| 17 | Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage,metastatic tumor burden,and doxorubicin-cyclophosphamide chemotherapy显示文摘 | Diaz-Montero CM Salem ML Nishimura MI | 2009 | Cancer Immunol Immunother2009，58，： | 1 |
| 18 | Increased circulating myeloid-derived suppressor ceils correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy显示文摘 | Diaz-Montero CM Salem ML Nishimura MI | 2009 | Cancer Immunol Immunother2009，58，1： | 1 |
| 19 | Antitumor immunization with a minimal peptide epitope (G9-209-2M) leads to a functionally heterogeneous CTL response 显示文摘 | Dudley ME Nishimura MI Holt AK | 1999 | J lmmunother1999，22，4： | 1 |
| 20 | Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma 显示文摘 | Dudley ME Wunderlich J Nishimura MI | 2001 | J Immunother2001，24，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员